Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer

This study has been completed.
Information provided by:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Identifier:
First received: December 9, 2002
Last updated: April 26, 2011
Last verified: April 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2006
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):